Evidence map›Paper›PMID 41898590›Full record

ArticleInternational journal of molecular sciences2026

ARPC2 Promotes Pulmonary Fibrosis by Regulating MRTFA Activity Independent of the Canonical ARP2/3 Complex.

Eun Jo Du, Hyunseong Kim, Seo-Gyeong Bae, Sihyeon An, Kanghyun Ryoo

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eun Jo DuSapiensBio Inc., Seongnam-si 13207, Gyeonggi-do, Republic of Korea.ORCID 0000-0002-5600-724X
Hyunseong KimSapiensBio Inc., Seongnam-si 13207, Gyeonggi-do, Republic of Korea.ORCID 0000-0001-8411-2082
Seo-Gyeong BaeSapiensBio Inc., Seongnam-si 13207, Gyeonggi-do, Republic of Korea.ORCID 0000-0001-8080-3783
Sihyeon AnYD Global Life Science Co., Ltd., Seongnam-si 13207, Gyeonggi-do, Republic of Korea.ORCID 0009-0003-6217-0750
Kanghyun RyooSapiensBio Inc., Seongnam-si 13207, Gyeonggi-do, Republic of Korea.

Funding

Korea Drug Development Fund RS-2023-00283815
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by the pathological accumulation of collagen-rich extracellular matrix, resulting in irreversible lung remodeling and respiratory failure. The incomplete understanding of IPF pathogenesis has hindered the development of effective therapeutics. Here, we investigate the mechanism by which the actin-related protein 2/3 complex subunit 2 (ARPC2) contributes to the fibrotic response in lung fibroblasts. Modulating of ARPC2 expression levels altered the expression of profibrotic genes, including α-smooth muscle actin (

Indexed as

Actin-Related Protein 2Actin-Related Protein 2-3 ComplexIdiopathic Pulmonary FibrosisPulmonary FibrosisTrans-ActivatorsActinsCell LineFibroblastsGene Expression RegulationHumansTransforming Growth Factor beta1Actin-Related Protein 2Actin-Related Protein 2-3 ComplexActinsACTR2 protein, humanTrans-ActivatorsTransforming Growth Factor beta1ARPC2fibroblast-to-myofibroblast transitionidiopathic pulmonary fibrosisMRTFA

Identifiers

PMID41898590
PMCPMC13027156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.